Contents
Special Focus – Prostate Cancer
VAL 201 – An Inhibitor of Androgen Receptor-associated Src and a Potential Treatment of Castration-resistant Prostate Cancer
Ferdinando Auricchio1 and Antimo Migliaccio1 1. Professor, Department of General Pathology, II University of Naples
Docetaxel Rechallenge in Patients with Castration-resistant Prostate Cancer – A Review Orazio Caffo,1
Giovanni Pappagallo,2 Lucianna Maria Russo,3 Antonello Veccia4 36 and Enzo Galligioni5
1. Senior Assistant and Chief of Day Hospital, Department of Medical Oncology, Santa Chiara Hospital; 2. Chief, Epidemiology and Clinical Trials Office, Oncology and Haematology Unit, Mirano; 3. Assistant, Department of Medical Oncology, Santa Chiara Hospital; 4. Assistant, Department of Medical Oncology, Santa Chiara Hospital; 5. Chief of Department, Department of Medical Oncology, Santa Chiara Hospital
Cabazitaxel in the Management of Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel-based Chemotherapy
Axel Heidenreich1 and David Pfister2 1. Chairman and Director; 2. Head Urologist, Conservative Uro-oncology, Department of Urology, RWTH Aachen University
Obesity in the Elderly – On the Role of Adipokines in Prostate Cancer Progression Adriano Angelucci1
and Mauro Bologna2
1. Assistant Professor of Immunology; 2. Professor of General Pathology, Department of Experimental Medicine, University of L’Aquila
46 32
42
Haematological Malignancies
Use of Bendamustine in Chronic Lymphocytic Leukaemia Patients with Co-morbidities Véronique Leblond
Professor and Head, Haematology Department, Pitié Salpêtrière Hospital, Paris 52
Paediatric Haematology
A Review of Sleep Concerns in Paediatric Sickle Cell Disease Lauren C Daniel1
and Lamia P Barakat1,2
1. Postdoctoral Researcher, Division of Oncology, The Children’s Hospital of Philadelphia; 2. Director of Psychosocial Services and Associate Professor of Clinical Psychology, Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania
58
Geriatric Oncology
Health Status Screening in Elderly Patients – Is this the Way Forward? Joanna Kazmierska
Radiation Oncologist and Head, Radiotherapy Department II, Greater Poland Cancer Centre and Research Associate, Poznan University of Medical Sciences
6 63
EUROPEAN ONCOLOGY & HAEMATOLOGY
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77